Establishment of a mouse hepatocellular carcinoma tumoroid panel recapitulating inter- and intra- heterogeneity for disease modelling and combinatorial drug discovery
Margherita Grattarola(Centre National de la Recherche Scientifique), Flavio Maina(Centre National de la Recherche Scientifique)
Cited by 3
Related Papers
The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active
|Nature Communications|2025|11